Logo image of IMMR

IMMERSION CORPORATION (IMMR) Stock Fundamental Analysis

NASDAQ:IMMR - Nasdaq - US4525211078 - Common Stock

8.55  -0.08 (-0.93%)

After market: 8.43 -0.12 (-1.4%)

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to IMMR. IMMR was compared to 32 industry peers in the Technology Hardware, Storage & Peripherals industry. IMMR scores excellent points on both the profitability and health parts. This is a solid base for a good stock. IMMR has a decent growth rate and is not valued too expensively. These ratings would make IMMR suitable for quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year IMMR was profitable.
IMMR had a negative operating cash flow in the past year.
IMMR had positive earnings in 4 of the past 5 years.
IMMR had a positive operating cash flow in 4 of the past 5 years.
IMMR Yearly Net Income VS EBIT VS OCF VS FCFIMMR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M

1.2 Ratios

IMMR's Return On Assets of 36.36% is amongst the best of the industry. IMMR outperforms 100.00% of its industry peers.
The Return On Equity of IMMR (44.16%) is better than 93.55% of its industry peers.
IMMR has a Return On Invested Capital of 37.87%. This is amongst the best in the industry. IMMR outperforms 96.77% of its industry peers.
IMMR had an Average Return On Invested Capital over the past 3 years of 9.10%. This is significantly below the industry average of 16.39%.
The 3 year average ROIC (9.10%) for IMMR is below the current ROIC(37.87%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 36.36%
ROE 44.16%
ROIC 37.87%
ROA(3y)13%
ROA(5y)5.72%
ROE(3y)15.61%
ROE(5y)6.28%
ROIC(3y)9.1%
ROIC(5y)N/A
IMMR Yearly ROA, ROE, ROICIMMR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

1.3 Margins

IMMR has a Profit Margin of 10.42%. This is amongst the best in the industry. IMMR outperforms 87.10% of its industry peers.
In the last couple of years the Profit Margin of IMMR has grown nicely.
Looking at the Operating Margin, with a value of 12.02%, IMMR belongs to the top of the industry, outperforming 80.65% of the companies in the same industry.
IMMR's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.02%
PM (TTM) 10.42%
GM N/A
OM growth 3Y94.23%
OM growth 5Y2.01%
PM growth 3Y78.19%
PM growth 5Y15.41%
GM growth 3YN/A
GM growth 5YN/A
IMMR Yearly Profit, Operating, Gross MarginsIMMR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100 -100

10

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IMMR is creating value.
IMMR has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, IMMR has more shares outstanding
There is no outstanding debt for IMMR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IMMR Yearly Shares OutstandingIMMR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
IMMR Yearly Total Debt VS Total AssetsIMMR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 9.41 indicates that IMMR is not in any danger for bankruptcy at the moment.
IMMR's Altman-Z score of 9.41 is amongst the best of the industry. IMMR outperforms 93.55% of its industry peers.
IMMR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 9.41
ROIC/WACC3.25
WACC11.65%
IMMR Yearly LT Debt VS Equity VS FCFIMMR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 6.44 indicates that IMMR has no problem at all paying its short term obligations.
With an excellent Current ratio value of 6.44, IMMR belongs to the best of the industry, outperforming 96.77% of the companies in the same industry.
A Quick Ratio of 6.44 indicates that IMMR has no problem at all paying its short term obligations.
IMMR's Quick ratio of 6.44 is amongst the best of the industry. IMMR outperforms 96.77% of its industry peers.
Industry RankSector Rank
Current Ratio 6.44
Quick Ratio 6.44
IMMR Yearly Current Assets VS Current LiabilitesIMMR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 138.10% over the past year.
The Earnings Per Share has been decreasing by -9.60% on average over the past years.
The Revenue has grown by 2512.31% in the past year. This is a very strong growth!
IMMR shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -21.11% yearly.
EPS 1Y (TTM)138.1%
EPS 3Y47.44%
EPS 5Y-9.6%
EPS Q2Q%931.26%
Revenue 1Y (TTM)2512.31%
Revenue growth 3Y3.61%
Revenue growth 5Y-21.11%
Sales Q2Q%6399.15%

3.2 Future

IMMR is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -33.01% yearly.
The Revenue is expected to grow by 265.82% on average over the next years. This is a very strong growth
EPS Next Y75.07%
EPS Next 2Y-33.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1039.86%
Revenue Next 2Y565.31%
Revenue Next 3Y265.82%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
IMMR Yearly Revenue VS EstimatesIMMR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
IMMR Yearly EPS VS EstimatesIMMR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 2

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 6.84, the valuation of IMMR can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of IMMR indicates a rather cheap valuation: IMMR is cheaper than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.29, IMMR is valued rather cheaply.
With a Price/Forward Earnings ratio of 15.24, IMMR is valued correctly.
Based on the Price/Forward Earnings ratio, IMMR is valued a bit cheaper than 61.29% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 24.44. IMMR is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 6.84
Fwd PE 15.24
IMMR Price Earnings VS Forward Price EarningsIMMR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IMMR is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.08
IMMR Per share dataIMMR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

IMMR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of IMMR may justify a higher PE ratio.
A cheap valuation may be justified as IMMR's earnings are expected to decrease with -33.01% in the coming years.
PEG (NY)0.09
PEG (5Y)N/A
EPS Next 2Y-33.01%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.11%, IMMR has a reasonable but not impressive dividend return.
IMMR's Dividend Yield is rather good when compared to the industry average which is at 2.93. IMMR pays more dividend than 87.10% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.28, IMMR has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.11%

5.2 History

IMMR has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
IMMR Yearly Dividends per shareIMMR Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

IMMR pays out 4.53% of its income as dividend. This is a sustainable payout ratio.
DP4.53%
EPS Next 2Y-33.01%
EPS Next 3YN/A
IMMR Yearly Income VS Free CF VS DividendIMMR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M
IMMR Dividend Payout.IMMR Dividend Payout, showing the Payout Ratio.IMMR Dividend Payout.PayoutRetained Earnings

IMMERSION CORPORATION

NASDAQ:IMMR (1/21/2025, 8:07:26 PM)

After market: 8.43 -0.12 (-1.4%)

8.55

-0.08 (-0.93%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)11-22 2024-11-22/amc
Earnings (Next)N/A N/A
Inst Owners64.28%
Inst Owner Change1.45%
Ins Owners5.09%
Ins Owner Change1.5%
Market Cap275.99M
Analysts82.5
Price Target14.03 (64.09%)
Short Float %11.33%
Short Ratio3.8
Dividend
Industry RankSector Rank
Dividend Yield 2.11%
Yearly Dividend0.23
Dividend Growth(5Y)N/A
DP4.53%
Div Incr Years0
Div Non Decr Years0
Ex-Date01-10 2025-01-10 (0.245)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)469.37%
Min Revenue beat(2)344.02%
Max Revenue beat(2)594.72%
Revenue beat(4)4
Avg Revenue beat(4)282.3%
Min Revenue beat(4)23.76%
Max Revenue beat(4)594.72%
Revenue beat(8)6
Avg Revenue beat(8)142.71%
Revenue beat(12)8
Avg Revenue beat(12)99.64%
Revenue beat(16)10
Avg Revenue beat(16)74.05%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)48.13%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1154.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 6.84
Fwd PE 15.24
P/S 0.32
P/FCF N/A
P/OCF N/A
P/B 1.37
P/tB 1.37
EV/EBITDA 0.08
EPS(TTM)1.25
EY14.62%
EPS(NY)0.56
Fwd EY6.56%
FCF(TTM)-1.91
FCFYN/A
OCF(TTM)-1.74
OCFYN/A
SpS26.45
BVpS6.24
TBVpS6.24
PEG (NY)0.09
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 36.36%
ROE 44.16%
ROCE 47.83%
ROIC 37.87%
ROICexc 229.01%
ROICexgc 229.01%
OM 12.02%
PM (TTM) 10.42%
GM N/A
FCFM N/A
ROA(3y)13%
ROA(5y)5.72%
ROE(3y)15.61%
ROE(5y)6.28%
ROIC(3y)9.1%
ROIC(5y)N/A
ROICexc(3y)48.9%
ROICexc(5y)N/A
ROICexgc(3y)48.9%
ROICexgc(5y)N/A
ROCE(3y)11.5%
ROCE(5y)N/A
ROICexcg growth 3Y84.52%
ROICexcg growth 5YN/A
ROICexc growth 3Y84.52%
ROICexc growth 5Y-44.16%
OM growth 3Y94.23%
OM growth 5Y2.01%
PM growth 3Y78.19%
PM growth 5Y15.41%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover3.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.44
Quick Ratio 6.44
Altman-Z 9.41
F-Score4
WACC11.65%
ROIC/WACC3.25
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)109.51%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)138.1%
EPS 3Y47.44%
EPS 5Y-9.6%
EPS Q2Q%931.26%
EPS Next Y75.07%
EPS Next 2Y-33.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2512.31%
Revenue growth 3Y3.61%
Revenue growth 5Y-21.11%
Sales Q2Q%6399.15%
Revenue Next Year1039.86%
Revenue Next 2Y565.31%
Revenue Next 3Y265.82%
Revenue Next 5YN/A
EBIT growth 1Y449.81%
EBIT growth 3Y101.23%
EBIT growth 5Y-19.52%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-259.62%
FCF growth 3YN/A
FCF growth 5Y-21.67%
OCF growth 1Y-244.13%
OCF growth 3Y909.9%
OCF growth 5Y-21.68%